Sean McCutcheon
Stock Analyst at Raymond James
(0.22)
# 4,249
Out of 4,918 analysts
9
Total ratings
22.22%
Success rate
-24.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $5.03 | +138.81% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $23.57 | +175.77% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $2.96 | +204.57% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.59 | +324.71% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $3.83 | +500.52% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $7.96 | +402.51% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $36.69 | +90.79% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $38.80 | +121.65% | 1 | Mar 13, 2024 |
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $5.03
Upside: +138.81%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $23.57
Upside: +175.77%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $2.96
Upside: +204.57%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.59
Upside: +324.71%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $3.83
Upside: +500.52%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $7.96
Upside: +402.51%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $36.69
Upside: +90.79%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $38.80
Upside: +121.65%